low-dose ozone exposure linked to 9% reduction in fasting blood glucose levels
Intravenous ozone therapy at low doses reduced fasting glucose levels by 9% (p<0.05) in metabolic syndrome patients.
What this means for you
Fasting glucose is a key marker of how well your body manages blood sugar day to day. A measurable drop in this number suggests ozone exposure may support healthier metabolic balance — something that matters for energy stability, weight management, and long-term vitality.
The published research
Changes In Biochemical Characteristics In Correction Of Metabolic Misbalance With
· 2002
This page describes a documented finding about the underlying wellness technology. It is not a marketing claim about any specific device. For information about HOCATT specifically, visit hocatt.com.